QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics...
QuidelOrtho (NASDAQ:QDEL) Posts Earnings Results, Beats Estimates By $0.18 EPS
12 Health Care Stocks Moving In Thursday's After-Market Session
QuidelOrtho shares are trading lower after the company reported Q2 financial results and cut its FY26 guidance below estimates.
QuidelOrtho FY26 Q2 GAAP net loss narrows to $93 million; revenue rises 3% to $631 million
QuidelOrtho | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 630.9 M
QuidelOrtho Corporation $QDEL Position Boosted by Segall Bryant & Hamill LLC